Aurinia Pharmaceuticals Inc., commonly referred to as Aurinia, is a biopharmaceutical company headquartered in Canada. Founded in 2013, Aurinia focuses on developing innovative therapies for autoimmune diseases, with a particular emphasis on lupus nephritis. The company has made significant strides in the industry, notably with the launch of its flagship product, LUPKYNIS™ (voclosporin), which offers a unique mechanism of action that enhances treatment options for patients. With a strong presence in North America and expanding operations in Europe, Aurinia has established itself as a leader in the autoimmune disease sector. The company’s commitment to research and development, coupled with its strategic partnerships, has positioned it favourably in the market, earning recognition for its contributions to patient care and treatment advancements.
How does Aurinia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Aurinia's score of 5 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Aurinia reported total carbon emissions of approximately 218,430 kg CO2e, a notable increase from about 198,740 kg CO2e in 2022. The emissions for 2022 were solely from Scope 2, indicating that the company has not reported any Scope 1 emissions. Despite the increase in total emissions, there are currently no disclosed reduction targets or climate pledges from Aurinia. This lack of specific commitments may reflect a broader industry context where many companies are still developing their climate strategies. Aurinia's headquarters in Canada positions it within a region increasingly focused on sustainability and emissions reduction, yet the absence of defined targets suggests an opportunity for the company to enhance its climate commitments moving forward.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2022 | |
---|---|
Scope 1 | - |
Scope 2 | 198,740 |
Scope 3 | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aurinia is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.